Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB080-00-AB (VRC01LS), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to Healthy Adults
Clinical trial NCT02599896 · COMPLETED
Trial details
- NCT number
- NCT02599896
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-16
- Primary completion
- 2018-07-25
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.